1. www.goldcopd.com. GOLD Workshop Report: Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Updated 2003.
2. Чучалин А.Г. Хронические обструктивные болезни легких. М.: БИНОМ; 1999.
3. Sandford A.J., Silverman E.K. Chronic obstructive pulmonary disease. 1: Susceptibility factors for COPD the genotype-environment interaction. Thorax 2002; 57:736-741.
4. DeMeo D.L., Silverman E.K. Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha (1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 2004; 59: 259-264.
5. Sandford A.J., Spinelli J.J., Weir T.D. et al. Mutation in the 3' region of the α1-antitrypsin gene and chronic obstructive pulmonary disease. J. Med. Genet. 1997; 34: 874-875.
6. Sandford A.J., Weir T.D., Spinelli J.J. et al. Z and S mutations of the α1 -antitrypsin gene and the risk of chronic obstructive pulmonary disease. Am. J. Respir. Cell. Mol. Biol. 1999; 20: 287-291.
7. Elkington P.T.G., Friedland J.S. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006; 61: 259-266.
8. Parks W.C., Shapiro S.D. Matrix metalloproteinases in lung biology. Respir. Res. 2001; 2 (1): 10-19.
9. Wallace A.M., Sandford A.J. Genetic polymorphisms of matrix metalloproteinases: functional importance in the development of chronic obstructive pulmonary disease? Am. J. Pharmacogenom. 2002; 2 (3): 167-175.
10. Atkinson J.J., Senior R.M. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell. Mol. Biol. 2003; 28 (1): 12-24.
11. Joos L., He J.Q., Shepherdson M.B. et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum. Mol. Genet. 2002; 11 (5): 569-576.
12. Segura)Valdez L., Pardo A., Gaxiola M. et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117 (3): 684-694.
13. Zhou M., Huang Sh., Wan H.)Y. et al. Genetic polymorphism in matrix metalloproteinase-9 and the susceptibility to chronic obstructive pulmonary disease in Han population of south China. Chin. Med. J. 2004; 117 (10): 1481-1484.